Research by Chiara Manzini, Ph.D., assistant professor in pharmacology & physiology, about a newly discovered mutation in the INPP5K gene, which suggests to a new type of congenital muscular dystrophy, was highlighted in an article in the March/April issue of Clinical OMICs. The research was also highlighted on BioNews, Drug Target Review, iTech Post, Life Science Daily, Medical News Today, Muscular Dystrophy News Today, and News-Medical.
Clinical OMICs - Gene Discovered for New Form of Muscular Dystrophy
Latest News
Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…